World Health Organization site
Skip Navigation Links
Home
Advanced Search
List ByExpand List By
Search Tips
UTNExpand UTN
ICTRP websiteExpand ICTRP website
Contact us
                   20887 records for 5980 trials found!
Trials are sometimes recorded in more than one registry. These records can refer to each other using the 'Secondary ID' field. The search portal uses these Secondary IDs to group records about the same trial together in the search results.
Each group of records referring to a trial is displayed in table that is seen by pressing the + symbol. The record with the earliest date of registration is always shown first.
 
 
 
 
  Showrecords per page     

1 2 3 4 5 6 7 8 9 10 Last
Recruitment statusMain ID Public TitleDate of Registration
RecruitingNCT02297971
Assessment of Coagulation and Thrombocyte Function After Termination of Ticagrelor
18/11/2014
RecruitingNCT02293421
Evaluation of the STOP-BANG Screening Questionnaire in a Sleep Clinic
13/11/2014
RecruitingISRCTN76738493
How and when is it most feasible to promote weight reduction after delivery in overweight women by motivational interviewing?
12/11/2014
RecruitingNCT02294929
Cryoballoon Ablation in Patients With Longstanding Persistent Atrial Fibrillation
12/11/2014
RecruitingNCT02291406
Importance of Surgical Approach for Gynecological Surgery on Metabolic Effects and Subsequent Recovery
11/11/2014
RecruitingNCT02290080
Determination of the Role of Oxygen in Suspected Acute Myocardial Infarction by Biomarkers
08/11/2014
RecruitingNCT02292277
Ticagrelor Pharmacokinetics in NSTEMI
05/11/2014
RecruitingISRCTN75766527
Evaluation of the effectiveness of a SMS based smoking cessation intervention among university students in Sweden ? the NEXit trial
04/11/2014
RecruitingNCT02290288
Prospective Study for Vaginal Vault Prolapse After Hysterectomy: Comparison of Two Surgical Methods
04/11/2014
AuthorisedEUCTR2014-000898-39-FI
Further 2 years of adjuvant imatinib may improve recurrence-free survival (RFS) of patients who are at a high risk of GIST recurrence despite completion of 3 years of adjuvant imatinib.
04/11/2014
    
1 2 3 4 5 6 7 8 9 10 Last
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.2 - Version history